Yoon Seong Choi1, Ho-Joon Lee1, Sung Soo Ahn1, Jong Hee Chang2, Seok-Gu Kang2, Eui Hyun Kim2, Se Hoon Kim3, Seung-Koo Lee4. 1. Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. 2. Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea. 3. Department of Pathology, Yonsei University College of Medicine, Seoul, Korea. 4. Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. SLEE@yuhs.ac.
Abstract
OBJECTIVES: To evaluate the ability of the initial area under the curve (IAUC) derived from dynamic contrast-enhanced MR imaging (DCE-MRI) and apparent diffusion coefficient (ADC) in differentiating between primary central nervous system lymphoma (PCNSL) and atypical glioblastoma (GBM). METHODS: We retrospectively identified 19 patients with atypical GBM (less than 13 % necrosis of the enhancing tumour), and 23 patients with PCNSL. The histogram parameters of IAUC at 30, 60, 90 s (IAUC30, IAUC60, and IAUC90), and ADC were compared between PCNSL and GBM. The diagnostic performances and added values of the IAUC and ADC for differentiating between PCNSL and GBM were evaluated. Interobserver agreement was assessed via intraclass correlation coefficient (ICC). RESULTS: The IAUC and ADC parameters were higher in GBM than in PCNSL. The 90th percentile (p90) of IAUC30 and 10th percentile (p10) of ADC showed the best diagnostic performance. Adding p90 of IAUC30 to p10 of ADC improved the differentiation between PCNSL and GBM (area under the ROC curve [AUC] = 0.886), compared to IAUC30 or ADC alone (AUC = 0.789 and 0.744; P < 0.05 for all). The ICC was 0.96 for p90 of IAUC30. CONCLUSIONS: The IAUC may be a useful parameter together with ADC for differentiating between PCNSL and atypical GBM. KEY POINTS: • High reproducibility is essential for practical implementation of advanced MRI parameters. • IAUC and ADC are highly reproducible parameters. • IAUC values were higher in atypical GBM than in PCNSL. • Adding IAUC to ADC improved the differentiation between PCNSL and GBM. • IAUC with ADC are useful for differentiating PCNSL from GBM.
OBJECTIVES: To evaluate the ability of the initial area under the curve (IAUC) derived from dynamic contrast-enhanced MR imaging (DCE-MRI) and apparent diffusion coefficient (ADC) in differentiating between primary central nervous system lymphoma (PCNSL) and atypical glioblastoma (GBM). METHODS: We retrospectively identified 19 patients with atypical GBM (less than 13 % necrosis of the enhancing tumour), and 23 patients with PCNSL. The histogram parameters of IAUC at 30, 60, 90 s (IAUC30, IAUC60, and IAUC90), and ADC were compared between PCNSL and GBM. The diagnostic performances and added values of the IAUC and ADC for differentiating between PCNSL and GBM were evaluated. Interobserver agreement was assessed via intraclass correlation coefficient (ICC). RESULTS: The IAUC and ADC parameters were higher in GBM than in PCNSL. The 90th percentile (p90) of IAUC30 and 10th percentile (p10) of ADC showed the best diagnostic performance. Adding p90 of IAUC30 to p10 of ADC improved the differentiation between PCNSL and GBM (area under the ROC curve [AUC] = 0.886), compared to IAUC30 or ADC alone (AUC = 0.789 and 0.744; P < 0.05 for all). The ICC was 0.96 for p90 of IAUC30. CONCLUSIONS: The IAUC may be a useful parameter together with ADC for differentiating between PCNSL and atypical GBM. KEY POINTS: • High reproducibility is essential for practical implementation of advanced MRI parameters. • IAUC and ADC are highly reproducible parameters. • IAUC values were higher in atypical GBM than in PCNSL. • Adding IAUC to ADC improved the differentiation between PCNSL and GBM. • IAUC with ADC are useful for differentiating PCNSL from GBM.
Entities:
Keywords:
ADC; DCE-MRI; DTI; Glioblastoma; Primary central nervous system lymphoma
Authors: Y S Choi; S S Ahn; H-J Lee; J H Chang; S-G Kang; E H Kim; S H Kim; S-K Lee Journal: AJNR Am J Neuroradiol Date: 2017-06-22 Impact factor: 3.825
Authors: J I Traylor; D C A Bastos; D Fuentes; M Muir; R Patel; V A Kumar; R J Stafford; G Rao; S S Prabhu Journal: AJNR Am J Neuroradiol Date: 2019-08-01 Impact factor: 3.825
Authors: Sachi Okuchi; Antonio Rojas-Garcia; Agne Ulyte; Ingeborg Lopez; Jurgita Ušinskienė; Martin Lewis; Sara M Hassanein; Eser Sanverdi; Xavier Golay; Stefanie Thust; Jasmina Panovska-Griffiths; Sotirios Bisdas Journal: Cancer Med Date: 2019-08-07 Impact factor: 4.452